ArticlePharmaceuticals (Basel, Switzerland)2021

Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates.

Hanah F Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.